Collaborative Arrangement, Rights And Obligations, Percentage Of Net Product Margin On Sales

No definition available.

Name:	akba_CollaborativeArrangementRightsAndObligationsPercentageOfNetProductMarginOnSales
Namespace Prefix:	akba_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Contract With Customer, Termination Notice Period

+ References

No definition available.

+ Details

Name:	akba_ContractWithCustomerTerminationNoticePeriod
Namespace Prefix:	akba_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Contract With Customer, Termination Notice Period, Period After Effective Agreement Date

+ References

No definition available.

+ Details

Name:	akba_ContractWithCustomerTerminationNoticePeriodPeriodAfterEffectiveAgreementDate
Namespace Prefix:	akba_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of performance obligations.

+ References

No definition available.

+ Details

Name:	akba_NumberOfPerformanceObligations
Namespace Prefix:	akba_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Revenue, Remaining Performance Obligation, Variable Consideration Amount

+ References

No definition available.

+ Details

Name:	akba_RevenueRemainingPerformanceObligationVariableConsiderationAmount
Namespace Prefix:	akba_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Revenue, Remaining Performance Obligation, Variable Consideration, Royalty, Expected Timing Of Satisfaction, Period

+ References

No definition available.

+ Details

Name:	akba_RevenueRemainingPerformanceObligationVariableConsiderationRoyaltyExpectedTimingOfSatisfactionPeriod
Namespace Prefix:	akba_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Definition

Revenue, Remaining Performance Obligation, Variable Consideration, Royalty Percentage

+ References

No definition available.

+ Details

Name:	akba_RevenueRemainingPerformanceObligationVariableConsiderationRoyaltyPercentage
Namespace Prefix:	akba_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481372/852-10-55-10

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481990/310-10-45-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481990/310-10-45-9

+ Details

Name:	us-gaap_AccountsReceivableNetCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479837/606-10-45-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479837/606-10-45-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-8

+ Details

Name:	us-gaap_ContractWithCustomerAssetNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479837/606-10-45-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-8

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479837/606-10-45-2

+ Details

Name:	us-gaap_ContractWithCustomerLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of noncurrent assets classified as other.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(17))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_OtherAssetsNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Cash receipts from customers during the current period which are usually for sales of goods and services.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_ProceedsFromCustomers
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=akba_MEDICEArzneimittelPutterGmbHCoKGMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=us-gaap_LicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=akba_MEDICEArzneimittelPutterGmbHCo.KGSideLetterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

LICENSE, COLLABORATION AND OTHER REVENUE - Medice License Agreement - Narrative (Details)		3 Months Ended
	May 24, 2023 USD ($) performance_obligation	Jun. 30, 2023 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Deferred revenue			$ 43,991,000
Other long-term assets			11,793,000	$ 12,423,000
Accounts receivable, net			26,620,000	39,290,000
Payables			11,882,000	14,635,000
MEDICE Arzneimittel Pütter GmbH & Co. KG \| Collaborative Arrangement, Transaction with Party to Collaborative Arrangement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage of net product margin on sales in collaborative arrangement	70.00%
MEDICE Arzneimittel Pütter GmbH & Co. KG \| License
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Deferred revenue	$ 10,000,000
Eligible milestone payments (up to)	$ 100,000,000
Tiered royalties, expected timing of satisfaction period	12 years
Termination of agreement by counterparty, written notice period	12 months
Termination of agreement eligible by counterparty, period after effective agreement date	12 months
Number of performance obligations \| performance_obligation	1
Proceeds from customers		$ 8,600,000
Other long-term assets			1,400,000	$ 1,400,000
MEDICE Arzneimittel Pütter GmbH & Co. KG \| License \| Minimum
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Tiered royalties	10.00%
MEDICE Arzneimittel Pütter GmbH & Co. KG \| License \| Maximum
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Tiered royalties	30.00%
MEDICE Arzneimittel Pütter GmbH & Co. KG, Side Letter \| License
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Deferred revenue			0
Accounts receivable, net			0
Payables			0
Contract asset			$ 0